Co-agonists of the GLP-1 and amylin receptors
MYPI2025003614A0Undetermined Publication Date: 2022-06-18NOVO NORDISK AS
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025003614
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-06-16
- Filing Date
- 2021-12-17
- Publication Date
- 2022-06-18
Abstract
The invention relates to a compound comprising a GLP-1 receptor agonist and an amylin receptor agonist. The invention also relates to a pharmaceutical formulation, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical formulation comprising it may be used for the medical treatment of subjects with overweight, obesity and associated co-morbidities.
Need to check novelty before this filing date? Find Prior Art
